The clinical global impressions scale: applying a research tool in clinical practice.
Joan Busner, Steven D Targum
https://pubmed.ncbi.nlm.nih.gov/20526405Actively Recruiting
Led by University Hospital Ostrava · Updated on 2024-02-02
150
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying the use of the Victo adjustable artificial sphincter to treat male patients who have urinary incontinence following prostate surgery. This prospective academic study aims to evaluate how well the device works and its safety in managing severe incontinence in this group. This non-interventional study includes adult males who have already undergone implantation of the Victo artificial sphincter. Before surgery, patients receive standard diagnostic tests. After activation of the device, they will have follow-up visits at 3 months and then annually. Patients can also contact the study center at any time if their symptoms worsen or if they face any complications. During the study, participants will complete tests such as the 24-hour pad-weight test to measure incontinence severity and patient questionnaires about their improvement. Researchers will follow patients for up to 5 years to assess treatment outcomes and safety. The total participation time varies based on follow-up but involves regular monitoring and the opportunity to report issues anytime.
CONDITIONS
Adjustable Artificial Sphincter Victo in the Treatment of Male Incontinence Due to Prostate Surgery
You may qualify if you...
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Short duration before procedure
Participants undergo a standard diagnostic work-up before the artificial sphincter procedure.
Duration - Procedure day and immediate recovery period
Participants have the Victo artificial sphincter surgically implanted due to severe urinary incontinence.
Duration - Up to 5 years
Participants attend regular visits starting 3 months after device activation and then every 12 months to monitor continence and device function. They may also contact the study center at any time if continence worsens or complications occur.
Regular visits: 1 visit at 3 months post-activation and annual visits thereafter
Total: 1 location
1
University Hospital Ostrava
Ostrava, Moravian-Silesian Region, Czechia, 70852
Actively Recruiting
J
Jiří Hynčica
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Joan Busner, Steven D Targum
https://pubmed.ncbi.nlm.nih.gov/20526405Peter Weibl, Rudi Hoelzel, Michael Rutkowski...
https://pubmed.ncbi.nlm.nih.gov/30038818Jan Krhut, Roman Zachoval, Phillip P Smith...
https://pubmed.ncbi.nlm.nih.gov/23797972